Mouse Anti Human Factor V

<strong>Mouse Anti Human Factor V</strong>_x000D_ <strong>Catalog number:</strong> B2017891_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 50 µg_x000D_ <strong>Molecular Weight or Concentration:</strong> N/A_x000D_ <strong>Supplied as:</strong> Solution_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -80¬∞C_x000D_ <strong>Keywords:</strong> Monoclonal antibody to human Factor V_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MŒ©-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Nichols WL, Gastineau DA, Solberg LA Jr, Mann KG. Identification of human megakaryocyte coagulation factor V Blood. 1985 Jun;65(6):1396-406._x000D_ 2: Annamalai AE, Stewart GJ, Hansel B, Memoli M, Chiu HC, Manuel DW, Doshi K, Colman RW. Expression of factor V on human umbilical vein endothelial cells is modulated by cell injury Arteriosclerosis. 1986 Mar-Apr;6(2):196-202._x000D_ 3: Katzmann JA, Nesheim ME, Hibbard LS, Mann KG. Isolation of functional human coagulation factor V by using a hybridoma antibody Proc Natl Acad Sci U S A. 1981 Jan;78(1):162-6._x000D_ 4: Yan SB, Nelson DR. Effect of factor V Leiden polymorphism in severe sepsis and on treatment with recombinant human activated protein C Crit Care Med. 2004 May;32(5 Suppl):S239-46._x000D_ 5: Maruyama I, Salem HH, Majerus PW. Coagulation factor Va binds to human umbilical vein endothelial cells and accelerates protein C activation J Clin Invest. 1984 Jul;74(1):224-30._x000D_ 6: Wong VM, Bienzle D, Hayes MA, Taylor P, Wood RD. Purification of protein C from canine plasma BMC Vet Res. 2014 Oct 18;10:251._x000D_ 7: Poncz M, Zaitsev SV, Ahn H, Kowalska MA, Bdeir K, Camire RM, Cines DB, Stepanova V. Packaging of supplemented urokinase into naked alpha-granules of in vitro -grown megakaryocytes for targeted therapeutic delivery bioRxiv [Preprint]. 2023 Dec 5:2023.12.05.570278._x000D_ 8: Cormier M, Burnett E, Mo A, Notley C, Tijet N, Christie-Holmes N, Hough C, Lillicrap D. Mice possess a more limited natural antihuman factor VIII antibody repertoire than humans that is produced disproportionately by marginal zone B cells J Thromb Haemost. 2024 Jan;22(1):76-89._x000D_ 9: Wood JP, Baumann Kreuziger LM, Ellery PER, Maroney SA, Mast AE. Reduced Prothrombinase Inhibition by Tissue Factor Pathway Inhibitor Contributes to the Factor V Leiden Hypercoagulable State Blood Adv. 2017 Feb 14;1(6):386-395._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/22001882">10: Hartman ZC, Wei J, Glass OK, Guo H, Lei G, Yang XY, Osada T, Hobeika A, Delcayre A, Le Pecq JB, Morse MA, Clay TM, Lyerly HK. Increasing vaccine potency through exosome antigen targeting Vaccine. 2011 Nov 21;29(50):9361-7. </a>_x000D_ _x000D_ <strong>Products Related to Mouse Anti Human Factor V can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>